Charles Schwab
OPTN

Charles Schwab’s OptiNose OPTN Stock Holding History

Charles Schwab’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,412
Closed -$24.2K – 3509
2024
Q3 		$24.2K Hold
2,412
– – ﹤0.01% 3474
2024
Q2 		$37.6K Sell
2,412
-11,109
-82% -$186K ﹤0.01% 3542
2024
Q1 		$296K Hold
13,521
– – ﹤0.01% 3178
2023
Q4 		$262K Hold
13,521
– – ﹤0.01% 3241
2023
Q3 		$249K Hold
13,521
– – ﹤0.01% 3247
2023
Q2 		$249K Buy
13,521
+11,109
+461% +$263K ﹤0.01% 3271
2023
Q1 		$69.8K Buy
2,412
+1,271
+111% +$33.8K ﹤0.01% 3294
2022
Q4 		$31.7K Hold
1,141
– – ﹤0.01% 3447
2022
Q3 		$63K Sell
1,141
-902
-44% -$49.5K ﹤0.01% 3277
2022
Q2 		$113K Sell
2,043
-449
-18% -$16.5K ﹤0.01% 3278
2022
Q1 		$93K Buy
+2,492
New +$89K ﹤0.01% 3428
2021
Q3 		– Sell
-10,950
Closed -$511K – 3536
2021
Q2 		$511K Sell
10,950
-5,587
-34% -$285K ﹤0.01% 3163
2021
Q1 		$916K Buy
16,537
+548
+3% +$33.3K ﹤0.01% 2888
2020
Q4 		$993K Buy
15,989
+1,094
+7% +$67K ﹤0.01% 2776
2020
Q3 		$872K Buy
14,895
+2,914
+24% +$216K ﹤0.01% 2708
2020
Q2 		$1.34M Buy
11,981
+1,183
+11% +$84.2K ﹤0.01% 2549
2020
Q1 		$728K Buy
10,798
+443
+4% +$44.6K ﹤0.01% 2577
2019
Q4 		$1.43M Buy
10,355
+1,544
+18% +$200K ﹤0.01% 2503
2019
Q3 		$926K Buy
8,811
+2,142
+32% +$214K ﹤0.01% 2599
2019
Q2 		$709K Buy
6,669
+1,097
+20% +$145K ﹤0.01% 2688
2019
Q1 		$861K Sell
5,572
-159
-3% -$18.4K ﹤0.01% 2598
2018
Q4 		$533K Buy
5,731
+416
+8% +$59.4K ﹤0.01% 2742
2018
Q3 		$991K Buy
5,315
+611
+13% +$174K ﹤0.01% 2628
2018
Q2 		$1.98M Buy
4,704
+3,126
+198% +$1.05M ﹤0.01% 2384
2018
Q1 		$474K Buy
1,578
+54
+4% +$15K ﹤0.01% 2746
2017
Q4 		$432K Buy
+1,524
New +$429K ﹤0.01% 2762

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Charles Schwab's OPTN Position: Q4 2024 in Review

Charles Schwab sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 2,412 shares — an estimated $24.2K sold.

Charles Schwab first reported a position in OPTN in Q4 2017 and held it in 26 quarters. The position peaked at $1.98M in Q2 2018. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Charles Schwab reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Charles Schwab sold 2,412 OptiNose shares in Q4 2024, an estimated $24.2K.
  • Charles Schwab first reported a position in OptiNose in Q4 2017 and held it in 26 quarters.
  • Charles Schwab's OptiNose position peaked at $1.98M in Q2 2018.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.